Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Our Mission: Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness

Please Join us for a Levy CIMAR seminar from Fatima Aysha Hussain, PhD, an Assistant Professor of Biology at Tufts studying the ecology and evolution of the vaginal microbiome. Dr. Hussain will present on “Designing Microbial Therapeutics for Vaginal Health” on May 29th at 12 noon in M&V 412 and by Zoom (details to come).

Dr. Hussain is interested in microbe-microbe interactions and phage-driven evolution of bacteria. She and her lab investigate how phages drive evolution of resistance in their hosts, how bacteriocins and other antimicrobial compounds shape the bacterial community, and how phage therapy might be leveraged in this ecosystem to treat microbial syndromes such as bacterial vaginosis. Dr. Hussain and team aim to use their work to design ecologically-informed microbial therapeutics for women’s health.

Previously, Dr. Hussain focused on clinical applications of this work—investigating the potential of newly-designed probiotics and vaginal microbiota transplantations to treat recurrent bacterial vaginosis.

You can learn more about Dr. Hussain and her lab via her website.

🎥ICYMI | #AntimicrobialStewardship in Critical Care Units
ISAC President Prof. Souha Kanj & renowned international experts explore cutting-edge strategies to optimise #antimicrobial use in ICUs in this webinar hosted by ISAC & @APUANews
https://youtu.be/W68zNURKPjw
#IDXposts

📢Happening tomorrow

#Antimicrobialstewardship in critical care units
📅3 April Hosted by ISAC/ @APUANews

Join ISAC President Prof. Souha Kanj & renowned experts as they explore cutting-edge strategies to optimise antimicrobial use in ICUs
Register⬇️
https://tinyurl.com/24cbevf3

Load More

Our Values

The Levy CIMAR is committed to a culture of diversity, equity, and inclusion both within our organization and for all people who are impacted by our work. We strive for health equity for people from all backgrounds and identities, and we actively support societal and institutional structures that promote justice and equality. We are also committed to being a safe, respectful, and inclusive environment for our trainees, staff, faculty, affiliates, and partners. One Health acknowledges the interconnectedness of all humans, along with animals and our environments. Antimicrobial resistance impacts us all.